Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NN INCNNBR · Entity 6041 | See Remarks | March 28, 2022 | March 30, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NN INC
Report date March 28, 2022 · Filed March 30, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 93,680 |
Reported balance
After 2022-03-28 transaction · row 1
1 source rowRow 1 · 2022-03-28 · Grant · Acquired 51,684 · Balance 93,680 F1: Shares are restricted stock and vest in three equal annual installments beginning on March 28, 2023. |
| Performance RightsSEC Table II · derivative / convertible security | Direct | 48,484 |
Reported balance
After 2022-03-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-03-28 · Grant · Acquired 48,484 · Balance 48,484 F2: Each performance right represents a contingent right to receive one share of common stock of NN, Inc. (the "Issuer"). F3: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of a custom S&P "MicroCap" Capital Goods Index over the period beginning on January 1, 2022 and ending December 31, 2024. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 25% and 150% of the target shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares are restricted stock and vest in three equal annual installments beginning on March 28, 2023.
F2: Each performance right represents a contingent right to receive one share of common stock of NN, Inc. (the "Issuer").
F3: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of a custom S&P "MicroCap" Capital Goods Index over the period beginning on January 1, 2022 and ending December 31, 2024. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 25% and 150% of the target shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 28, 2022 Filed Mar 30, 2022 20:45 UTC | NN INC NNBR · Entity 6041 | GrantPerformance Rights · Derivative | 48,484 | $0.00 | $0.00 |
DisclosureSEC source: 0000918541-22-000065 · wf-form4_164867312771869.xml · derivative · entry 2 BUCHAN JOHN · CIK 0001789436 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,484 Underlying: Common Stock · 48,484 shares Expires not disclosed F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of common stock of NN, Inc. (the "Issuer"). F3 · derivative.exercise_date: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of a custom S&P "MicroCap" Capital Goods Index over the period beginning on January 1, 2022 and ending December 31, 2024. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 25% and 150% of the target shares. F3 · derivative.expiration_date: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of a custom S&P "MicroCap" Capital Goods Index over the period beginning on January 1, 2022 and ending December 31, 2024. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 25% and 150% of the target shares. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 20:45 UTC | NN INC NNBR · Entity 6041 | GrantCommon Stock | 51,684 | $0.00 | $0.00 |
DisclosureSEC source: 0000918541-22-000065 · wf-form4_164867312771869.xml · nonDerivative · entry 1 BUCHAN JOHN · CIK 0001789436 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,680 F1 · kind: Shares are restricted stock and vest in three equal annual installments beginning on March 28, 2023. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 21:36 UTC | NN INC NNBR · Entity 6041 | SaleCommon Stock | 48,052 | $4.09 | $196,623.98 |
DisclosureSEC source: 0000918541-21-000050 · wf-form4_164029536900271.xml · nonDerivative · entry 1 BUCHAN JOHN · CIK 0001789436 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,996 F1 · kind: The sale was made in connection with Executive's tax planning for 2021. Executive intends to repurchase an equal number of shares in 2022, subject to compliance with laws and company policies, as well as then-market conditions. F2 · price: This transaction was executed in multiple trades at prices ranging from $4.0000 to $4.2100. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 20:05 UTC | NN INC NNBR · Entity 6041 | GrantPerformance Rights · Derivative | 16,609 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-013468 · doc4.xml · derivative · entry 2 BUCHAN JOHN · CIK 0001789436 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,609 Underlying: Common Stock · 16,609 shares Expires not disclosed F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of common stock of NN, Inc. (the "Issuer"). F3 · derivative.exercise_date: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2021 and ending December 31, 2023. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. F3 · derivative.expiration_date: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2021 and ending December 31, 2023. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 20:05 UTC | NN INC NNBR · Entity 6041 | GrantCommon Stock | 20,138 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-013468 · doc4.xml · nonDerivative · entry 1 BUCHAN JOHN · CIK 0001789436 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,048 F1 · kind: Shares are restricted stock and vest in three equal annual installments beginning on March 23, 2022. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 20:05 UTC | NN INC NNBR · Entity 6041 | Tax withholdingCommon Stock | 1,708 | $7.82 | $13,356.56 |
DisclosureSEC source: 0000899243-21-011929 · doc4.xml · nonDerivative · entry 1 BUCHAN JOHN · CIK 0001789436 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,910 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 23:06 UTC | NN INC NNBR · Entity 6041 | Tax withholdingCommon Stock | 14,842 | $6.81 | $101,074.02 |
DisclosureSEC source: 0000899243-21-007586 · doc4.xml · nonDerivative · entry 1 BUCHAN JOHN · CIK 0001789436 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,618 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:19 UTC | NN INC NNBR · Entity 6041 | GrantPerformance Rights · Derivative | 13,233 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-005293 · doc4.xml · derivative · entry 2 BUCHAN JOHN · CIK 0001789436 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,233 Underlying: Common Stock · 13,233 shares Expires not disclosed F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of common stock of NN, Inc. (the "Issuer"). F3 · derivative.exercise_date: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2020 and ending December 31, 2022. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. F3 · derivative.expiration_date: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2020 and ending December 31, 2022. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:19 UTC | NN INC NNBR · Entity 6041 | GrantCommon Stock | 60,028 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-005293 · doc4.xml · nonDerivative · entry 1 BUCHAN JOHN · CIK 0001789436 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,460 F1 · kind: Shares are restricted stock with 15,007 shares vesting in three equal annual installments beginning on February 18, 2021 with the remaining 45,021 shares vesting in full on February 18, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.